ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022
Broadband Enhancement of Cherenkov Radiation Using Dispersionless Plasmons.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 30 citations in OpenAlex.
- Transverse-Electric Cherenkov Radiation for TeV-Scale Particle Detection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- A gain route to reversed Cherenkov radiation.Science advances · 2025Article
- Observations of Cherenkov-Like Radial Wake in Water Waves.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- Free-electron resonance transition radiation via Brewster randomness.Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- Terahertz Amplification Induced by Electron-Phonon Interactions in Gated Graphene Plasmonic System.Research (Washington, D.C.) · 2025Article
- In-Plane Radiation of Surface Plasmon Polaritons Excited by Free Electrons.Micromachines · 2024Article
- Free-electron Brewster-transition radiation.Science advances · 2023Article
- Shaping free-electron radiation via van der Waals heterostructures.Light, science & applications · 2023Article
- Broadband Enhancement of Cherenkov Radiation Using Dispersionless Plasmons.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
Abstract
As one of leading technologies in detecting relativistic particles, Cherenkov radiation plays an essential role in modern high-energy and particle physics. However, the limited photon yield in transparent dielectrics makes efficient Cherenkov radiation only possible with high-energy particles (at least several MeV). This restriction hinders applications of Cherenkov radiation in free-electron light source, bio-imaging, medical therapy, etc. Broadband enhancement of Cherenkov radiation is highly desired for all these applications, but still widely acknowledged as a scientific challenge. To this end, a general approach is reported to enhance the photon yield of Cherenkov radiation using dispersionless plasmons. Broadband dispersionless plasmons can be realized by exploiting either the acoustic nature of terahertz plasmons in a graphene-based heterostructure or the nonlocal property of optical plasmons in a metallodielectric structure. When coupled to moving electrons, such dispersionless plasmons give rise to a radiation enhancement rate more than two orders of magnitude (as compared with conventional Cherenkov radiation) over an ultrabroad frequency band. Moreover, since the phase velocity of dispersionless plasmons can be made as small as the Fermi velocity, giant radiation enhancements can be readily induced by ultralow-energy free electrons (e.g., with a kinetic energy down to 3 eV), without resorting to relativistic particles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.